SROA SoundBoard - Anne Hubbard & Dr. Constatine Mantz

 

Questions Answered During Podcast: 

1. Why did ASTRO develop the radiation oncology case rate value-based payment program, also called ROCR?
2. Can you provide a brief overview of the ROCR model and highlight how it differs from the ROAPM?
3. What kind of feedback have you been getting from cancer centers as you're introducing the model and trying to move forward with this as something that CMS should adopt?
4. Why is the legislative path better than the other route?
5. Mantz, as a practicing radiation oncologist who's also engaged at the health policy level, what are your thoughts or impressions of the ROCR model versus the ROAPM in terms of the practical implementation part of it?
6. Can you share some data points regarding the impact?
7. Why do they keep cutting it when they know it's so expensive?
8. Let's assume scenario in which ROCR is implemented. Will it become mandatory for all cancer centers across the United States to participate in it?
9. To administrators who went through all the pains of the metrics, of the RO-APM, what would you tell them that would be different under ROCR?
10. How will ROCR take into account different size cancer centers like the rural, freestanding, academic medical centers and not be the one size fits all?
11. For administrators who either want to learn more about ROCR or get on board, so to speak, in terms of helping to move it forward to on the legislative path, what advice would you give to them?
12. What is next in terms of trying to get ROCR passed into law, especially given there's an election? What are you hoping for or trying to achieve before the next election?
13. Do you have any final thoughts that you'd like to share?